Medical Oncology

Multiple Myeloma

Questions discussed in this category

What is your current practice for de-escalation of frequency of administration of bispecific antibodies among responders in patients with relapsed/refractory multiple myeloma?

1 Answer available

Papers discussed in this category

Blood, 2024 Aug 08

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study.

Nature medicine, 2023 Aug 15

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results.

Related Topics in Medical Oncology